Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 5,742 shares at $3.17 ($19K) on 2023-03-21, disclosed to the SEC on 2023-03-22.
Scheduled purchase ($19k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.28 | 3,006 | $10K | 53.2% |
| 2 | $3.17 | 2,736 | $9K | 46.8% |
| Total | $3.23 avg | 5,742 | $19K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |